ES2035317T5 - Metodo para analizar celulas hematopoyeticas en una muestra. - Google Patents

Metodo para analizar celulas hematopoyeticas en una muestra.

Info

Publication number
ES2035317T5
ES2035317T5 ES88310507T ES88310507T ES2035317T5 ES 2035317 T5 ES2035317 T5 ES 2035317T5 ES 88310507 T ES88310507 T ES 88310507T ES 88310507 T ES88310507 T ES 88310507T ES 2035317 T5 ES2035317 T5 ES 2035317T5
Authority
ES
Spain
Prior art keywords
sample
analyzing
cells
hematopoyetic
hematopoyetic cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88310507T
Other languages
English (en)
Other versions
ES2035317T3 (es
Inventor
Michael R Loken
Virendra O Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22378975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2035317(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Publication of ES2035317T3 publication Critical patent/ES2035317T3/es
Application granted granted Critical
Publication of ES2035317T5 publication Critical patent/ES2035317T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N2015/1006—Investigating individual particles for cytology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1402—Data analysis by thresholding or gating operations performed on the acquired signals or stored data
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1477—Multiparameters
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

UN METODO Y CONJUNTO PARA LA IDENTIFICACION DE ORIGENES Y ETAPAS DE CELULAS HEMATOPOYETICAS EN UNA MUESTRA, DONDE LAS CELULAS SE TRATAN CON ANTICUERPOS MONOCLONALES MARCADOS ELEGIDOS PARA DISTINGUIR ENTRE CADA ORIGEN Y ETAPAS DE MADURACION DENTRO DE CADA ORIGEN.
ES88310507T 1987-11-09 1988-11-08 Metodo para analizar celulas hematopoyeticas en una muestra. Expired - Lifetime ES2035317T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11849887A 1987-11-09 1987-11-09

Publications (2)

Publication Number Publication Date
ES2035317T3 ES2035317T3 (es) 1993-04-16
ES2035317T5 true ES2035317T5 (es) 1998-03-16

Family

ID=22378975

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88310507T Expired - Lifetime ES2035317T5 (es) 1987-11-09 1988-11-08 Metodo para analizar celulas hematopoyeticas en una muestra.

Country Status (7)

Country Link
US (1) US5137809A (es)
EP (1) EP0317156B2 (es)
JP (1) JPH06105253B2 (es)
AT (1) ATE81724T1 (es)
DE (1) DE3875456T3 (es)
ES (1) ES2035317T5 (es)
GR (2) GR3006183T3 (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013974A1 (en) * 1990-03-14 1991-09-19 The Biomembrane Institute Monoclonal antibody and immunoconjugates for the treatment and detection of b cell disorders
US5622853A (en) * 1990-05-01 1997-04-22 Becton Dickinson And Company T lymphocyte precursor
US5367057A (en) * 1991-04-02 1994-11-22 The Trustees Of Princeton University Tyrosine kinase receptor flk-2 and fragments thereof
US5185438A (en) * 1991-04-02 1993-02-09 The Trustees Of Princeton University Nucleic acids encoding hencatoporetic stem cell receptor flk-2
GR920100123A (el) * 1991-04-12 1993-03-16 Ortho Diagnostic Systems Inc Αντιδραστήριο πολυχρωματικής κηλίδωσης και μέ?οδος ανάλυσης.
FR2676847A1 (fr) * 1991-05-22 1992-11-27 Immunotech Sa Procede d'enumeration des reticulocytes et les kits destines a cette enumeration.
FR2684186B1 (fr) * 1991-11-25 1994-02-25 Pasteur Sanofi Diagnostics Trousse pour le denombrement rapide des granulocytes, et procede utilisant ladite trousse.
ES2051651B1 (es) * 1992-12-10 1995-01-01 Univ Salamanca Procedimiento para la cuantificacion simultanea, en una sola medicion, de los principales tipos de linfocitos humanos y sus subpoblaciones.
US5692220A (en) * 1993-09-02 1997-11-25 Coulter Corporation Decision support system and method for diagnosis consultation in laboratory hematopathology
EP0685071A4 (en) * 1993-11-12 2000-12-13 Becton Dickinson Co METHOD FOR ABSOLUTE COUNTING OF RARE CELLS
FI951778A (fi) * 1995-04-12 1996-10-13 Aboatech Ab Oy Menetelmä allergian toteamiseksi
US5876956A (en) * 1995-05-15 1999-03-02 Johns Hopkins University School Of Medicine Methods for identification or purification of cells containing an enzymatic intracellular marker
US5877299A (en) * 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US6306575B1 (en) 1995-06-16 2001-10-23 Stemcell Technologies, Inc. Methods for preparing enriched human hematopoietic cell preparations
US6117985A (en) 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
JP2000500337A (ja) * 1995-11-13 2000-01-18 コールター コーポレイション 細胞の集団又は亜集団のバルク濃縮のための方法および装置
JP3574665B2 (ja) * 1996-09-06 2004-10-06 メダレツクス・インコーポレーテツド シアニジン組成物並びにそれらの治療的及び診断的使用
JP3620946B2 (ja) 1997-03-17 2005-02-16 シスメックス株式会社 スキャッタグラムの表示方法および粒子計測装置
AU3712200A (en) * 1999-03-01 2000-09-21 Board Of Trustees Of The Leland Stanford Junior University Rapid assay for chorioamnionitis
WO2000052472A1 (en) * 1999-03-01 2000-09-08 The Board Of Trustees Of The Leland Stanford Junior University Rapid assay for infection in small children
WO2000062071A1 (de) 1999-04-13 2000-10-19 Wilex Ag Diagnostischer und therapeutischer einsatz von antikörpern gegen den urokinase-rezeptor
US6900023B1 (en) 1999-09-02 2005-05-31 Sysmex Corporation Method for classifying and counting leukocytes
US7300763B2 (en) 2000-06-08 2007-11-27 Teijin Limited Method of testing myelotoxicity with the use of flow cytometer
WO2003067210A2 (en) 2001-07-10 2003-08-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting the activation state of the multiple proteins in single cells
US7393656B2 (en) * 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
US7381535B2 (en) 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
US7695926B2 (en) 2001-07-10 2010-04-13 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting receptor-ligand interactions in single cells
DE60208341T2 (de) * 2002-05-14 2006-09-28 Universidad De Salamanca Multidimensionale Analyse von Leukozyten
DK1458853T3 (da) * 2002-05-16 2010-04-06 Absorber Ab Fremgangsmåde til donorspecifik krydsmatchning
CA2872136C (en) * 2002-07-18 2017-06-20 Merus B.V. Recombinant production of mixtures of antibodies
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
US7507548B2 (en) 2003-03-04 2009-03-24 University Of Salamanca Multidimensional detection of aberrant phenotypes in neoplastic cells to be used to monitor minimal disease levels using flow cytometry measurements
CA2527694C (en) * 2003-05-30 2015-07-14 Hendricus Renerus Jacobus Mattheus Hoogenboom Fab library for the preparation of anti vegf and anti rabies virus fabs
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
EP1737971B1 (en) 2004-01-20 2017-08-16 Merus N.V. Mixtures of binding proteins
ES2521620T3 (es) * 2004-03-03 2014-11-13 Universidad De Salamanca Método para la detección multidimensional de fenotipos aberrantes en células neoplásicas para su uso para monitorizar niveles mínimos de enfermedad utilizando citometría de flujo
CA2559110A1 (en) * 2004-03-09 2005-09-15 Absorber Ab Endothelial progenitor cells and methods of use thereof
US7674598B2 (en) 2004-05-21 2010-03-09 Beckman Coulter, Inc. Method for a fully automated monoclonal antibody-based extended differential
US7625712B2 (en) 2004-05-21 2009-12-01 Beckman Coulter, Inc. Method for a fully automated monoclonal antibody-based extended differential
JP3968383B2 (ja) * 2004-09-01 2007-08-29 株式会社日本メディカル総研 血液細胞の新規分類法ならびにそれを利用したテイラーメード治療および予防
CN105168250B (zh) 2004-10-25 2019-02-05 塞勒兰特治疗公司 增殖骨髓细胞群体的方法及其应用
CN101102791B (zh) 2004-11-18 2011-12-14 英克隆有限责任公司 抗血管内皮生长因子受体-1的抗体
US20070009923A1 (en) * 2005-01-24 2007-01-11 Massachusetts Institute Of Technology Use of bayesian networks for modeling cell signaling systems
US7321843B2 (en) * 2005-09-30 2008-01-22 Universidad De Salamanca Method for generating new flow cytometry data files containing an infinite number of dimensions based on data estimation
AU2005234696B2 (en) 2005-11-18 2012-02-16 Phanos Technologies, Inc. Fluorescent membrane intercalating probes and methods for their use
CN101421393B (zh) * 2006-02-14 2013-08-14 塞勒兰特治疗公司 提高造血干细胞植入的方法和组合物
US7816135B2 (en) 2007-07-05 2010-10-19 Becton, Dickinson And Company Method of analyzing lymphocytes
WO2009058876A1 (en) 2007-10-29 2009-05-07 Beckman Coulter, Inc. Method for a rapid antibody-based analysis of platelet populations
EP3670538A1 (en) 2008-04-25 2020-06-24 Dyax Corp. Antibodies against fcrn and use thereof
GB2474146B (en) * 2008-04-29 2013-04-10 Nodality Inc Methods of determining the health status of an individual
US20090291458A1 (en) * 2008-05-22 2009-11-26 Nodality, Inc. Method for Determining the Status of an Individual
US8399206B2 (en) 2008-07-10 2013-03-19 Nodality, Inc. Methods for diagnosis, prognosis and methods of treatment
WO2010006291A1 (en) 2008-07-10 2010-01-14 Nodality, Inc. Methods for diagnosis, prognosis and treatment
EP2349329A4 (en) 2008-10-14 2012-10-31 Dyax Corp USE OF IGF-II / IGF-II BINDING FOR THE TREATMENT AND PREVENTION OF SYSTEMIC SCLEROSIS ASSOCIATED WITH LUNG FIBROSIS
US20100099109A1 (en) * 2008-10-17 2010-04-22 Nodality, Inc., A Delaware Corporation Methods for Analyzing Drug Response
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
LT2521568T (lt) 2010-01-06 2018-12-10 Dyax Corp. Plazmos kalikreiną surišantys baltymai
JP5952815B2 (ja) 2010-08-04 2016-07-13 シズル バイオテクノロジー リミテッド ガンの診断および処置のための方法および化合物
AU2011332815A1 (en) 2010-11-23 2013-05-30 Presage Biosciences, Inc. Therapeutic methods and compositions for solid delivery
CA2837527C (en) 2011-06-02 2019-05-28 Dyax Corp. Fc receptor binding proteins
ES2743399T3 (es) 2012-04-20 2020-02-19 Merus Nv Métodos y medios para la producción de moléculas heterodiméricas similares a Ig
WO2014022376A2 (en) 2012-08-01 2014-02-06 United Therapeutics Corporation Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
JP6901823B2 (ja) 2012-08-01 2021-07-14 ユナイテッド セラピューティクス コーポレイション 間葉系幹細胞による肺動脈性高血圧症の処置
EP3878452B1 (en) 2013-01-09 2023-09-20 United Therapeutics Corporation Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
US9839653B2 (en) 2013-10-24 2017-12-12 Neuroplast Beheer B.V. Method for reducing the inflammatory activity of a stem cell transplant and use thereof
US20180214488A1 (en) 2015-07-20 2018-08-02 Angiocrine Bioscience, Inc. Methods and compositions for stem cell transplantation
WO2017066561A2 (en) 2015-10-16 2017-04-20 President And Fellows Of Harvard College Regulatory t cell pd-1 modulation for regulating t cell effector immune responses
US20210309965A1 (en) 2016-03-21 2021-10-07 Dana-Farber Cancer Institute, Inc. T-cell exhaustion state-specific gene expression regulators and uses thereof
IL266175B2 (en) 2016-10-24 2024-01-01 United Therapeutics Corp Enhancement of immunomodulatory properties of MSC using treprostinil
US20210263019A1 (en) * 2020-02-25 2021-08-26 Becton, Dickinson And Company Bi-specific probes to enable the use of single-cell samples as single color compensation control
US11932901B2 (en) 2020-07-13 2024-03-19 Becton, Dickinson And Company Target enrichment using nucleic acid probes for scRNAseq
WO2022216942A1 (en) 2021-04-07 2022-10-13 Dana-Farber Cancer Institute, Inc. Compositions and methods for the treatment of cancer
WO2023086969A2 (en) 2021-11-12 2023-05-19 Ichor Medical Systems Inc. Treatment methods

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53107413A (en) * 1977-03-02 1978-09-19 Nippon Baiotesuto Kenkiyuushiy Detecting method and reagent kit for antibody against leucocyte
DE2953610T1 (de) * 1979-03-19 1981-04-23 Diagnostic Techn Int Inc Double tagged immunoassay
JPS5745454A (en) * 1980-09-02 1982-03-15 Fuji Photo Film Co Ltd Immunochemical measuring method for various minor components
JPS58171671A (ja) * 1982-04-01 1983-10-08 Fujitsu Ltd 細胞分類方法
US4607007A (en) * 1983-04-07 1986-08-19 Becton, Dickinson And Company Differentiation of natural killer cell subpopulations of cells
US4581334A (en) * 1983-04-25 1986-04-08 Ortho Diagnostics Systems, Inc. Simultaneous detection of leukocyte phagocytic and killing ability
US4599307A (en) * 1983-07-18 1986-07-08 Becton, Dickinson And Company Method for elimination of selected cell populations in analytic cytology
US4645738A (en) * 1983-09-30 1987-02-24 Memorial Sloan-Kettering Institute Cancer Center Method for differential diagnosis of T cell leukemias using monoclonal antibodies
US4599304A (en) * 1983-10-07 1986-07-08 Becton, Dickinson And Company Method for monitoring activated cell subpopulations
US4654312A (en) * 1984-05-14 1987-03-31 Becton, Dickinson And Company Lysing agent for analysis of peripheral blood cells
JPH0652409B2 (ja) * 1984-08-08 1994-07-06 富士写真フイルム株式会社 ハロゲン化銀カラー写真感光材料
US4677061A (en) * 1984-10-19 1987-06-30 Genetic Systems Corporation T-cell lymphocyte subset monitoring of immunologic disease
US4727020A (en) * 1985-02-25 1988-02-23 Becton, Dickinson And Company Method for analysis of subpopulations of blood cells
CA1279008C (en) * 1985-10-11 1991-01-15 Smith Kline & French Canada Ltd. Methods and reagents for performing subset analysis
DE3541033A1 (de) * 1985-11-19 1987-05-21 Boehringer Mannheim Gmbh Verfahren zur quantifizierung von zellpopulationen bzw. subpopulationen sowie hierfuer geeignetes reagenz

Also Published As

Publication number Publication date
US5137809A (en) 1992-08-11
DE3875456T2 (de) 1993-03-04
JPH01161153A (ja) 1989-06-23
DE3875456D1 (de) 1992-11-26
ES2035317T3 (es) 1993-04-16
JPH06105253B2 (ja) 1994-12-21
EP0317156B2 (en) 1997-11-12
EP0317156A1 (en) 1989-05-24
EP0317156B1 (en) 1992-10-21
ATE81724T1 (de) 1992-11-15
GR3006183T3 (en) 1993-06-21
DE3875456T3 (de) 1998-06-10
GR3025901T3 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
ES2035317T5 (es) Metodo para analizar celulas hematopoyeticas en una muestra.
GB2055851A (en) Method and kit for enzyme immunoassay of biological substances
ES526991A0 (es) Un metodo para evaluar la probabilidad de malignidad celular en una muestra biologica de un haspedante humano.
DE3774739D1 (de) Fluoreszenzpolarisationsimmunoassays und darin zu verwendende reagenzien.
DE3481775D1 (de) Verfahren zum raschen nachweis von mikroorganismen in klinischen proben.
DE3173597D1 (en) Specific antibody and its use in an enzyme immuno assay
NO165598C (no) Fremgangsmaate for ekspresjon av hepatitt b overflateantigen i cellekultur samt ekspresjonsvektor.
BR8108803A (pt) Processo e aparelho para determinacao quantitativa do nivel de hemoglobina em uma amostra biologica
ES511797A0 (es) "metodo para ensayar reacciones antigeno-anticuerpo".
IT8124286A0 (it) Apparato per analizzare e valutare campioni per saggi contenuti in una pluralita' di cellette.
GB2082321B (en) Method and kit for labelling red blood cells with technetium-99m
DE2965570D1 (en) Method for the detection and/or determination of an antigen specific immunoglobulin, immuno-reagents to be used in said method and test kit for said determination
DE3884731D1 (de) Monoklonaler Antikörper gegen Methamphetamin, seine Herstellung, Testverfahren und Testsatz für Methamphetamin.
JPS5526899A (en) Measuring of amino group transfering enzyme in biological fluid and combination reagent used therein
BR8107322A (pt) Processo de analise de organismos presentes no meio rural
ATE71149T1 (de) Monoklonale antikoerper.
DE3765147D1 (de) Verfahren und reagenz zur bestimmung von gesamt-bilirubin.
IT1141587B (it) Laboratorio prefabbricato e analizzatore di ottano
IT1114891B (it) Metodo e corredo di prova per la determinazione di amilasi nel siero
ES8606948A1 (es) Mejoras intruducidas en un ensayo para determinar un antigeno bacteriano en una muestra de ensayo
NZ227184A (en) Method, slide and kit for assaying collagenolytic activity of mammalian biological fluids involving the use of collagen
JPS5526895A (en) Enzyme measuring method * reagent and test kit
JPS576364A (en) Immunologic inspection of oncofetal antigent and diagnostic method and kit utilizing thereof
SE468853B (sv) Nytt lymfokin, monoklonala antikroppar specifika foer lymfokinet och deras framstaellning samt anvaendningar
BR8502804A (pt) Corantes reativos,processo para sua obtencao e utilizacao

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 317156

Country of ref document: ES